Synovial sarcoma (SS) is an aggressive, SS18::SSX fusion oncogene-driven cancer typically presenting in periarticular tissues of adolescents and young adults, accounting for about 5% of soft tissue sarcomas. Here, SSX2 is linked to synovial sarcoma.